Photocure $PHO.OL stock could break out after Q3 presentation

Photocure PHO presented Q3 numbers with top line numbers just a hint weaker than consensus, but with the strongest quarterly growth rate in deployed cystoscopes ever noted.

The stock is currently trading above earlier support, and a move through NOK 60 could trigger a strong BUY signal.


Q3 Report:
https://photocure.com/globalassets/investor-relations/quarterly-reports/2019/pho-q3-2019-rep.pdf


Q3 webcast in english with CEO Daniel Schneider of Photocure:
https://webtv.hegnar.no/presentation.php?webcastId=98164404


Beyond Technical AnalysisbiotechbladdercancerParallel ChannelSupport and Resistance

Ngoài ra, trên:

Thông báo miễn trừ trách nhiệm